Back to Trials
NCT01772602Recruiting

The National Amyotrophic Lateral Sclerosis Registry

Centers for Disease Control and Prevention

Start Date

10/1/2010

Completion Date

12/1/2040

Summary

The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.

Detailed Description

The National ALS Registry's Research Notification System allows person with ALS to participate in clinical trials.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: \- U.S. citizens 18 years of age or older Exclusion Criteria: \-

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Amyotrophic Lateral Sclerosis

Locations

CDC

Atlanta, Georgia 30333

United States